| Briefing Date: | 12/13/2011 |
| Topic: | Scientific Standards for Studies on Modified Risk Tobacco Products |
THE NATIONAL ACADEMIES
Institute of Medicine
Board on Population Health and Public Health Practice
Committee on Scientific Standards for Studies on Modified Risk Tobacco Products
*****
Congressional Briefings
Tuesday, December 13, 2011
2218 Rayburn House Office Bldg. – 10:00 a.m.
and
430 Dirksen Senate Office Bldg. – 4:00 p.m.
on
Scientific Standards for Studies on Modified Risk Tobacco Products
by
Jane E. Henney, M.D., Professor of Medicine and Public Health Sciences, College of Medicine, University of Cincinnati at Cincinnati; and Chair, Committee on Scientific Standards for Studies on Modified Risk Tobacco Products, Institute of Medicine, The National Academies
Bonnie L. Halpern-Felsher, Ph.D., Professor, Department of Pediatrics, Division of Adolescent Medicine, University of California at San Francisco; and Member, Committee on Scientific Standards for Studies on Modified Risk Tobacco Products, Institute of Medicine, The National Academies
and
Richard O'Connor, Ph.D., Associate Member, Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, N.Y.; and Member, Committee on Scientific Standards for Studies on Modified Risk Tobacco Products, Institute of Medicine, The National Academies
Modified risk tobacco products aim to reduce tobacco-related illnesses, and the Food and Drug Administration (FDA) is responsible for their scientific assessment and ongoing review. This new report, from the Institute of Medicine, advises FDA on the minimum standards for scientific studies to allow the marketing of modified risk tobacco products and for postmarket studies of approved products.
These series of briefings were for members of Congress and congressional staff only. The report was publicly released on December 14, 2011 and can be found, in its entirety, on the Web site of the National Academies Press.
|
|
Subscribe to e-newsletters |
Feedback | Back to Top